Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTD1801 in Primary Biliary Cholangitis (PRONTO-PBC)
NCT04604652Phase 2Completed
- Sponsor
- HighTide Therapeutics, Inc.
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of berberine ursodeoxycholate in primary biliary cholangitis (PBC), sponsored by HighTide Therapeutics, Inc.. Started May 2021; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT04604652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604652.